Abstract
The use of ziconotide in intrathecal analgesia intrathecally is sometimes limited by dose-related side effects. We present our experience with the combination of ziconotide and sufentanil as intrathecal polytherapy in a patient with chronic low back pain.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Neuromodulation: Technology at the Neural Interface
Paper Title
Journal
Date
